{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:59Z","timestamp":1759048019870},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1007\/s11908-996-0033-5","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T21:39:37Z","timestamp":1180733977000},"page":"116-122","source":"Crossref","is-referenced-by-count":17,"title":["Campylobacter enteritis and the Guillain-Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"3","author":[{"given":"Irving","family":"Nachamkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"33_CR1","first-page":"815","volume":"33","author":"T Escherich","year":"1886","unstructured":"Escherich T: Beitrage zur kenntniss der darmbacterien.III. Ueber das vorkommen von bironen im darmcanal und den stuhlgangen der sauglinge [Aricles adding to the knowledge of intestinal bacteria.III. On the existence of vibrios in the intestines and faces of babies]. Munchener Medicinische Wochenschrift 1886, 33:815\u2013817.","journal-title":"Munchener Medicinische Wochenschrift"},{"key":"33_CR2","first-page":"xvii","volume-title":"Campylobacter","author":"MB Skirrow","year":"2000","unstructured":"Skirrow MB, Butzler J-P: Foreword. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:xvii-xxiii.","edition":"edn 2"},{"key":"33_CR3","first-page":"189","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention: Incidence of foodborne illnesses: preliminary data from the Foodborne Diseases Active Surveillance Network (FoodNet) United States, 1998. MMWR 1999, 48:189\u2013194.","journal-title":"MMWR"},{"key":"33_CR4","first-page":"121","volume-title":"Campylobacter","author":"CR Friedman","year":"2000","unstructured":"Friedman CR, Neimann J, Wegener HC, Tauxe RV: Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:121\u2013138. This review is the most up-to-date summary and analysis of the epidemiology of Campylobacter infections in the United States and other industrialized nations. Much of the data is derived from new active surveillance programs initiated by the Centers for Disease Control and Prevention.","edition":"edn 2"},{"key":"33_CR5","first-page":"69","volume-title":"Campylobacter","author":"MB Skirrow","year":"2000","unstructured":"Skirrow MB, Blaser MJ: Clinical aspects of Campylobacter infection. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:69\u201388.","edition":"edn 2"},{"key":"33_CR6","first-page":"467","volume-title":"Campylobacter","author":"W Jacobs-Reitsma","year":"2000","unstructured":"Jacobs-Reitsma W: Campylobacter in the food supply. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:467\u2013481.","edition":"edn 2"},{"key":"33_CR7","first-page":"3","volume-title":"Campylobacter","author":"P Vandamme","year":"2000","unstructured":"Vandamme P: Taxonomy of the family Campylobacteraceae. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:3\u201326.","edition":"edn 2"},{"key":"33_CR8","doi-asserted-by":"crossref","unstructured":"Guerrant RL, Van Gilder T, Steiner TS, et al.: Guidelines for managing infectious diarrhea. Clin Infect Dis 2001, in press. This new Infectious Diseases Society of America (IDSA) Practice Guideline was just completed and submitted for publication. IDSA publishes numerous practice guidelines of major interest to both physicians specializing in infectious diseases as well as general medicine. Access to these practice guidelines can be found at the IDSA web site (www.idsociety.org).","DOI":"10.1086\/318514"},{"key":"33_CR9","first-page":"716","volume-title":"Manual of Clinical Microbiology","author":"I Nachamkin","year":"1999","unstructured":"Nachamkin I: Campylobacter and Arcobacter. In Manual of Clinical Microbiology, edn 7. Edited by Murray PR, Baron EJ, Pfaller MA, et al. Washington, DC: ASM Press; 1999:716\u2013726.","edition":"edn 7"},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/clinids\/23.6.1292","volume":"23","author":"J Hines","year":"1996","unstructured":"Hines J, Nachamkin I: Effective use of the clinical microbiology laboratory for diagnosing diarrheal diseases. Clin Infect Dis 1996, 23:1292\u20131301.","journal-title":"Clin Infect Dis"},{"key":"33_CR11","first-page":"45","volume-title":"Campylobacter","author":"I Nachamkin","year":"2000","unstructured":"Nachamkin I, Engberg J, Aarestrup FM: Diagnosis and antimicrobial susceptibility of Campylobacter species. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:45\u201366.","edition":"edn 2"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/JCM.38.8.3076-3079.2000","volume":"38","author":"M Hindiyeh","year":"2000","unstructured":"Hindiyeh M, Jense S, Hohmann S, et al.: Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area. J Clin Microbiol 2000, 38:3076\u20133079.","journal-title":"J Clin Microbiol"},{"key":"33_CR13","doi-asserted-by":"crossref","unstructured":"Engberg J, Aarestrup FM, Taylor DE, et al.: Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: a review of mechanisms and trends over time of resistance profiles in human isolates. Emerg Infect Dis 2001, in press. This article presents a summary of antimicrobial resistance trends in Campylobacter over the past decade.","DOI":"10.3201\/eid0701.010104"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199905203402001","volume":"340","author":"KE Smith","year":"1999","unstructured":"Smith KE, Besser JM, Hedberg CW, et al.: Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992\u20131998. N Engl J Med 1999, 340:1525\u20131532. An important study on the epidemiology of quinolone-resistant C. jejuni infections in Minnesota.","journal-title":"N Engl J Med"},{"key":"33_CR15","first-page":"300","volume":"3","author":"I Nachamkin","year":"1994","unstructured":"Nachamkin I: Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli to ciprofloxacin, erythromycin and tetracycline from 1982 to 1992. Med Microbiol Lett 1994, 3:300\u2013305.","journal-title":"Med Microbiol Lett"},{"key":"33_CR16","first-page":"483","volume-title":"Campylobacter","author":"KE Smith","year":"2000","unstructured":"Smith KE, Bender JB, Osterholm MT: Antimicrobial resistance in animals and relevance to human infections. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:483\u2013495.","edition":"edn 2"},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.neuro.21.1.187","volume":"21","author":"TW Ho","year":"1998","unstructured":"Ho TW, McKhann GM, Griffin JW: Human autoimmune neuropathies. Ann Rev Neurosci 1998, 21:187\u2013226. An excellent review on the pathogenesis of a variety of peripheral autoimmune diseases including a detailed description on the pathogenesis of GBS.","journal-title":"Ann Rev Neurosci"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmj.285.6336.173","volume":"285","author":"KM Rhodes","year":"1982","unstructured":"Rhodes KM, Tattersfield AE: Guillain-Barre syndrome associated with Campylobacter infection. Br Med J 1982, 285:173\u2013174.","journal-title":"Br Med J"},{"key":"33_CR19","first-page":"155","volume-title":"Campylobacter","author":"I Nachamkin","year":"2000","unstructured":"Nachamkin I, Allos BM, Ho TW: Campylobacter jejuni infection and the association with Guillain-Barr\u00e9 syndrome. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:155\u2013175. An excellent review on the association of C. jejuni with GBS.","edition":"edn 2"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410330304","volume":"33","author":"S Kuroki","year":"1993","unstructured":"Kuroki S, Saida T, Nukina M, et al.: Campylobacter jejuni strains from patients with Guillain-Barre syndrome belong mostly to Penner serogroup 19 and contain B-N-acetylglucosamine residues. Ann Neurol 1993, 33:243\u2013247.","journal-title":"Ann Neurol"},{"key":"33_CR21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.410420107","volume":"42","author":"N Yuki","year":"1997","unstructured":"Yuki N, Takahashi M, Tagawa Y, et al.: Association of Campylobacter jejuni serotype and antiganglioside antibody in Guillain-Barre syndrome and Fisher\u2019s syndrome. Ann Neurol 1997, 42:28\u201333.","journal-title":"Ann Neurol"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.51.2.371","volume":"51","author":"KA Sheikh","year":"1998","unstructured":"Sheikh KA, Nachamkin I, Ho TW, et al.: Campylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome: molecular mimicry and host susceptibility. Neurology 1998, 51:371\u2013378.","journal-title":"Neurology"},{"key":"33_CR23","unstructured":"Nachamkin I, Arzarte Barbosa P, Flores L, et al.: Campylobacter jejuni and Guillain-Barre syndrome in Mexico City: a prospective culture based analysis of O serotypes associated with the disease [abstract]. In Abstracts of the 10th International Workshop on Campylobacter, Helicobacter & Related Organisms. Baltimore: September 11\u201316, 1999."},{"key":"33_CR24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/adc.76.6.526","volume":"76","author":"EA Goddard","year":"1997","unstructured":"Goddard EA, Lastovica AJ, Argent AC: Campylobacter O:41 isolation in Guillain-Barr\u00e9 syndrome. Arch Dis Child 1997, 76:526\u2013528.","journal-title":"Arch Dis Child"},{"key":"33_CR25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2958.2000.01717.x","volume":"35","author":"AV Karlyshev","year":"2000","unstructured":"Karlyshev AV, Linton D, Gregson NA, et al.: Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol Microbiol 2000, 35:529\u2013541.","journal-title":"Mol Microbiol"},{"issue":"suppl 2","key":"33_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/513793","volume":"176","author":"RAC Hughes","year":"1997","unstructured":"Hughes RAC, Rees JH: Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome. J Infect Dis 1997, 176(suppl 2):92\u201398.","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"33_CR27","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1086\/513785","volume":"176","author":"JC Buzby","year":"1997","unstructured":"Buzby JC, Mishu Allos BM, Roberts T: The economic burden of Campylobacter associated Guillain-Barr\u00e9 syndrome. J Infect Dis 1997, 176(suppl 2):S192-S197.","journal-title":"J Infect Dis"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/jb.173.2.618-626.1991","volume":"173","author":"AP Moran","year":"1991","unstructured":"Moran AP, Rietschel ET, Kosunen TU, Zahringer U: Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2, 3-dideoxy-D-glucose. J Bacteriol 1991, 173:618\u2013626.","journal-title":"J Bacteriol"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","volume":"178","author":"N Yuki","year":"1993","unstructured":"Yuki N, Taki T, Inagaki F, et al.: A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside structure. J Exp Med 1993, 178:1771\u20131775.","journal-title":"J Exp Med"},{"key":"33_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/bi00167a032","volume":"33","author":"GO Aspinall","year":"1994","unstructured":"Aspinall GO, McDonald AG, Pang H, et al.: Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barr\u00e9 syndrome. Biochemistry 1994, 33:241\u2013249.","journal-title":"Biochemistry"},{"key":"33_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","volume":"122","author":"KA Sheikh","year":"1999","unstructured":"Sheikh KA, Deerinck TJ, Ellisman MH, Griffin JW: The distribution of ganglioside-like moieties in peripheral nerves. Brain 1999, 122:449\u2013460.","journal-title":"Brain"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/314725","volume":"179","author":"I Nachamkin","year":"1999","unstructured":"Nachamkin I, Ung H, Moran AP, et al.: Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J Infect Dis 1999, 179:1183\u20131189.","journal-title":"J Infect Dis"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","volume":"45","author":"TW Ho","year":"1999","unstructured":"Ho TW, Willison H, Nachamkin I, et al.: Anti-GD1a antibody distinguishes axonal from demyelinating forms of Guillain-Barr\u00e9 syndrome. Ann Neurol 1999, 45:168\u2013173.","journal-title":"Ann Neurol"},{"key":"33_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/35001088","volume":"403","author":"J Parkhill","year":"2000","unstructured":"Parkhill J, Wren BW, Mungall K, et al.: The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000, 403:665\u2013668. This study describes the complete genome sequence of C. jejuni NCTC11168 and is the culmination of several years of work by many investigators to sequence this organism. The results should pave the way for major advances in understanding the pathogenesis of how Campylobacter causes disease.","journal-title":"Nature"},{"key":"33_CR35","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1074\/jbc.275.6.3896","volume":"275","author":"M Gilbert","year":"2000","unstructured":"Gilbert M, Brisson JR, Karwaski MF, et al.: Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. J Biol Chem 2000, 275:3896\u20133906. A major paper conclusively showing the role of several sialyltransferases in the production of ganglioside mimicry in C. jejuni.","journal-title":"J Biol Chem"},{"key":"33_CR36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1365-2958.2000.01780.x","volume":"35","author":"D Linton","year":"2000","unstructured":"Linton D, Karlyshev AV, Hitchen PG, et al.: Multiple N-acetyl neuramic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialyation of lipo-oligosaccharide. Mol Microbiol 2000, 35:1120\u20131134.","journal-title":"Mol Microbiol"},{"key":"33_CR37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2958.2000.02020.x","volume":"37","author":"D Linton","year":"2000","unstructured":"Linton D, Gilbert M, Hitchen PG, et al.: Phase variation of a B-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol 2000, 37:501\u2013514.","journal-title":"Mol Microbiol"},{"key":"33_CR38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","volume":"104","author":"CS Goodyear","year":"1999","unstructured":"Goodyear CS, O\u2019Hanlon GM, Plomp JJ, et al.: Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 1999, 104:697\u2013708. A major study describing an ex vivo model for studying the pathogenesis of GBS and the role of pathogenic antiganglioside antibodies in disease.","journal-title":"J Clin Invest"},{"key":"33_CR39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1099\/00207713-50-2-865","volume":"50","author":"JMJ Logan","year":"2000","unstructured":"Logan JMJ, Burnens A, Linton D, et al.: Campylobacter lanienae sp. nov., a new species isolated from workers in an abattoir. Int J Sys Evol Microbiol 2000, 50:865\u2013872.","journal-title":"Int J Sys Evol Microbiol"},{"key":"33_CR40","first-page":"89","volume-title":"Campylobacter","author":"AJ Lastovica","year":"2000","unstructured":"Lastovica AJ, Skirrow MB: Clinical significance of Campylobacter and related species other than Campylobacter jejuni. In Campylobacter, edn 2. Edited by Nachamkin I, Blaser MJ. Washington, DC: ASM Press; 2000:89\u2013121.","edition":"edn 2"},{"key":"33_CR41","unstructured":"National Antimicrobial Resistance Monitoring System:Enteric Bacteria 1998 Annual Report. Atlanta: Centers for Disease Control and Prevention; 1998."},{"key":"33_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5694\/j.1326-5377.1987.tb133228.x","volume":"147","author":"BR Speed","year":"1987","unstructured":"Speed BR, Kaldor J, Watson J, et al.: Campylobacter jejuni\/ Campylobacter coli associated Guillain-Barre syndrome. Med J Aust 1987, 147:13\u201316.","journal-title":"Med J Aust"},{"key":"33_CR43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archneur.1988.00520300075022","volume":"45","author":"AH Ropper","year":"1988","unstructured":"Ropper AH: Campylobacter diarrhea and Guillain-Barre syndrome. Arch Neurol 1988, 45:655\u2013656.","journal-title":"Arch Neurol"},{"key":"33_CR44","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archneur.1991.00530220102027","volume":"48","author":"R Gruenwald","year":"1991","unstructured":"Gruenwald R, Ropper AH, Lior H, et al.: Serologic evidence of Campylobacter jejuni\/coli enteritis in patients with Guillain-Barr\u00e9 syndrome. Arch Neurol 1991, 48:1080\u20131082.","journal-title":"Arch Neurol"},{"key":"33_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410340208","volume":"34","author":"U Enders","year":"1993","unstructured":"Enders U, Karch H, Toyka KV, et al.: The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barr\u00e9 syndrome and in other neuroimmunological disorders. Ann Neurol 1993, 34:136\u2013144.","journal-title":"Ann Neurol"},{"key":"33_CR46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"JH Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RAC: Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med 1995, 333:1374\u20131379.","journal-title":"N Engl J Med"},{"key":"33_CR47","first-page":"267","volume":"19","author":"H Hariharan","year":"1996","unstructured":"Hariharan H, Naseema K, Kumaran C, et al.: Detection of Campylobacter jejuni\/C. coli infection in patients with Guillain-Barr\u00e9 Syndrome by serology and culture. New Microbiologica 1996, 19:267\u2013271.","journal-title":"New Microbiologica"},{"key":"33_CR48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-5728(96)00162-2","volume":"73","author":"NA Gregson","year":"1997","unstructured":"Gregson NA, Rees JH, Hughes RAC: Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barr\u00e9 syndrome (GBS). J Neuroimmunol 1997, 73:28\u201336.","journal-title":"J Neuroimmunol"},{"key":"33_CR49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0161-6420(98)97034-8","volume":"105","author":"K Ohtsuka","year":"1998","unstructured":"Ohtsuka K, Nakamura Y, Hashimoto M, et al.: Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology 1998, 105:1281\u20131285.","journal-title":"Ophthalmology"},{"key":"33_CR50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(97)00166-5","volume":"81","author":"Q Hao","year":"1998","unstructured":"Hao Q, Saida T, Kuroki S, et al.: Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barr\u00e9 syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 1998, 81:116\u2013126.","journal-title":"J Neuroimmunol"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-996-0033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-996-0033-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-996-0033-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:00:21Z","timestamp":1587574821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-996-0033-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s11908-996-0033-5","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}